|
DrugLogic, Inc. is a software company headquartered in Reston, Virginia. It has offices in Boston, Massachusetts, Princeton, New Jersey, San Diego, California, and Irvine, California. The company provides analytic, workflow, and risk management software and services for the pharmaceutical and related industries. The product line includes * Qscan-ERM, the analytic, workflow, and risk management platform * Qnome, a specialized version of Qscan-ERM for use with genomic information. * Qmap, a platform for mapping structured data. ==U.S. Patents== DrugLogic, Inc. is granted or is in the process of applying for the following patents with the United States Patent and Trademark Office: * 6,778,994 Pharmacovigilance database〔(Pharmacovigilance database )〕 * 6,789,091 Method and system for web-based analysis of drug adverse effects〔(Method and system for web-based analysis of drug adverse effects )〕 * 7,461,006 Method and system for the analysis and association of patient-specific and population-based genomic data with drug safety adverse event data〔Method and system for the analysis and association of patient-specific and population-based genomic data with drug safety adverse event data ()〕 * 7,542,961 Method and system for analyzing drug adverse effects〔(Method and system for analyzing drug adverse effects )〕 * 7,925,612 Method for graphically depicting drug adverse effect risks〔(Method for graphically depicting drug adverse effect risks )〕 * 8,694,555 Processing drug data〔(Processing drug data )〕 * Method and system for drug utilization review〔(Method and system for drug utilization review )〕 * Method and system for the analysis and association of patient-specific and population-based genomic data with drug safety adverse event data〔Method and system for the analysis and association of patient-specific and population-based genomic data with drug safety adverse event data ()〕 * Method and system for creating, storing and using patient-specific and population-based genomic drug safety data〔Method and system for creating, storing and using patient-specific and population-based genomic drug safety data ()〕 * Method and system for analyzing drug adverse effects〔(Method and system for analyzing drug adverse effects )〕 * Method for analyzing drug adverse effects employing multivariate statistical analysis〔Method for analyzing drug adverse effects employing multivariate statistical analysis ()〕 抄文引用元・出典: フリー百科事典『 ウィキペディア（Wikipedia）』 ■ウィキペディアで「DrugLogic」の詳細全文を読む スポンサード リンク
|